[1]
J. de Sá, “Regarding the Article: ‘Multiple Sclerosis Treatment with Natalizumab: Analysis of a Hospital-Based Cohort’”, Acta Med Port, vol. 27, no. 4, pp. 409–410, Aug. 2014.